Letrozole 112809-51-5 Oncology
1.Product Name: letrozole 2.CAS NO: 112809-51-5 3.Appearance: White powder 4.letrozole Content: 99.9% 5.Molecular Formula: C17H11N5 Introduction Letrozole is an oral non-steroidal inhibitor for the treatment of hormonally-responsive breast cancer after surgery. Letrozole prevents the aromatase from producing estrogens by competitive, reversible binding to the heme of its cytochrome p450 unit, the action is specific,and letrozol does not reduce production of mineralo-or corticosteroids. Function and usage Pyrrole type aromatization enzyme inhibitors. Used in the treatment of breast cancer.
1.Product Name: letrozole 2.CAS NO: 112809-51-5 3.Appearance: White powder 4.letrozole Content: 99.9% 5.Molecular Formula: C17H11N5 Introduction Letrozole is an oral non-steroidal inhibitor for the treatment of hormonally-responsive breast cancer after surgery. Letrozole prevents the aromatase from producing estrogens by competitive, reversible binding to the heme of its cytochrome p450 unit, the action is specific,and letrozol does not reduce production of mineralo-or corticosteroids. Function and usage Pyrrole type aromatization enzyme inhibitors. Used in the treatment of breast cancer.
CAS NO:25781-92-4
CAS NO:10047-33-3
CAS NO:131-55-5
CAS NO:501-98-4
CAS NO:103-90-2
CAS NO:110-63-4
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View